The SARS-CoV-2 Antigen Rapid Test is intended for the qualitative in vitro detection of SARS-CoV-2 antigen in human nasopharynx or oropharynx swabs. The new SARS-CoV-2 variant from Great Britain is also recognized.
High sensitivity and sensitivity
Helps with the quick identification of potentially infectious patients - even those without symptoms
The execution of the test is not automated and does not require any special training